The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
Read More Drugs (Pharmaceuticals), Health Insurance and Managed Care, Prices (Fares, Fees and Rates), Medicare, Inflation Reduction Act of 2022, Suits and Litigation (Civil), Merck & Company Inc
